As of 2025-08-04, the Relative Valuation of Abbott Laboratories (ABT) is 215.95 USD. This relative valuation is based on P/E multiples. With the latest stock price at 127.29 USD, the upside of Abbott Laboratories based on Relative Valuation is 69.7%.
The range of the Relative Valuation is 128.73 - 358.18 USD.
| Range | Selected | |
| Trailing P/E multiples | 29.8x - 44.6x | 37.3x |
| Forward P/E multiples | 31.1x - 35.2x | 31.9x |
| Fair Price | 128.73 - 358.18 | 215.95 |
| Upside | 1.1% - 181.4% | 69.7% |
| Date | P/E |
| 2025-08-01 | 15.84 |
| 2025-07-31 | 15.71 |
| 2025-07-30 | 16.00 |
| 2025-07-29 | 15.93 |
| 2025-07-28 | 15.73 |
| 2025-07-25 | 15.75 |
| 2025-07-24 | 15.64 |
| 2025-07-23 | 15.66 |
| 2025-07-22 | 15.65 |
| 2025-07-21 | 15.49 |
| 2025-07-18 | 15.39 |
| 2025-07-17 | 15.00 |
| 2025-07-16 | 16.40 |
| 2025-07-15 | 16.37 |
| 2025-07-14 | 16.43 |
| 2025-07-11 | 16.43 |
| 2025-07-10 | 16.63 |
| 2025-07-09 | 16.58 |
| 2025-07-08 | 16.60 |
| 2025-07-07 | 16.64 |
| 2025-07-03 | 16.73 |
| 2025-07-02 | 16.69 |
| 2025-07-01 | 16.96 |
| 2025-06-30 | 16.93 |
| 2025-06-27 | 16.73 |
| 2025-06-26 | 16.64 |
| 2025-06-25 | 17.10 |
| 2025-06-24 | 17.19 |
| 2025-06-23 | 16.59 |
| 2025-06-20 | 16.55 |
| 2025-06-18 | 16.48 |
| 2025-06-17 | 16.46 |
| 2025-06-16 | 16.68 |
| 2025-06-13 | 16.88 |
| 2025-06-12 | 16.98 |
| 2025-06-11 | 16.84 |
| 2025-06-10 | 16.69 |
| 2025-06-09 | 16.60 |
| 2025-06-06 | 16.63 |
| 2025-06-05 | 16.67 |
| 2025-06-04 | 16.55 |
| 2025-06-03 | 16.64 |
| 2025-06-02 | 16.62 |
| 2025-05-30 | 16.63 |
| 2025-05-29 | 16.53 |
| 2025-05-28 | 16.43 |
| 2025-05-27 | 16.55 |
| 2025-05-23 | 16.34 |
| 2025-05-22 | 16.37 |
| 2025-05-21 | 16.56 |